# Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery

> **NCT00458549** · NA · TERMINATED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 232 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** omega-3 fatty acids
- **PROCEDURE:** biopsy

## Key facts

- **NCT ID:** NCT00458549
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-05-27
- **Primary completion:** 2009-05-14
- **Final completion:** 2012-05-01
- **Target enrollment:** 232 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2018-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00458549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00458549, "Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00458549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*